Newsletter
S2 003: Barbara Domayne-Hayman ➡️ From big pharma to biotech startups & investing. 🧪🧬🤖

The Healthtech VC

S2 003: Barbara Domayne-Hayman ➡️ From big pharma to biotech startups & investing. 🧪🧬🤖

June 5, 2022

S2 003: Barbara Domayne-Hayman ➡️ From big pharma to biotech startups & investing. 🧪🧬🤖

From a PhD in chemistry to big pharma and biotech to startups and now investing, Barbara successfully navigates a portfolio career.

Today, she sits on the investment committees of the Cambridge Enterprise seed fund and Life Arc’s seed fund. She is also the entrepreneur in Residence at the Francis Crick Institute in London. She also runs the KQ Labs accelerator, helping data-driven scientist and health founders commercialise their ideas. Two of our portfolio companies, Mendelian and Charco Neurotech, have been through the KQ Labs programme.

An alumna of the London Business School Sloan programme, Barbara has fearlessly navigated multiple career transitions, from big pharma to biotech to startups and investing. Today, she is also an angel investor and a member of the Cambridge Angels angel investor network.

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

Top Health Podcasts. Delivered to Your Inbox and Eardrums.

Join Our Newsletter

Proudly supported by:

cover
Treatment for Alzheimer’s Disease: Diet, Exercise and Lifestyle Changes Hear from people living with Alzheimer's about lifestyle changes they’ve adopted to continue leading active, social lives.